Our Parallel Trade Expertise

Publications February 2, 2023

Outlook 2023: Firms Prepare For ‘World Where Health Care Has No Limits’

In the latest publication by Medtech Insights by Pharma Intelligence, executives at top device companies and other stakeholders share their expectations.

MedTech Pharma

Events January 27, 2023

Alira Health and Biocat Startup Support Program Presentation

Biocat and Alira Health partnered to foster Market Access for startups. Alira Health, a global healthcare advisory and technology company, and Biocat, a strategic stakeholder building(...)

Market Access Startups

Publications January 20, 2023

Insights on Market Access

To get her perspective on market access and what to expect in 2023, we spoke with Nerea Blanqué, Senior Vice President of Market Access and Pricing at Alira Health.

Market Access Medical Devices Pharma

Publications January 18, 2023

The State of Biopharma Funding

We spoke with Joris Pezzini, Executive Vice President of Biopharma, Alira Health, during the J.P. Morgan Healthcare Conference in San Francisco, which brings together investors and(...)

Biopharma Biotech Funding Pharma

Publications December 21, 2022

2022 Recap: Your Favorite Alira Health Publications

In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)

Clinical Digital Health Market Access MedTech Pharma Regulatory

News November 15, 2022

Alira Health Partners with Policy Matters to Foster Market Access in the UK

Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announces its partnership with leading UK market access specialist(...)

Digital Health Healthcare Consulting Market Access

News November 10, 2022

Alira Health and GDMH together to boost Life Sciences innovation

The companies join forces for collaborative research and co-development of projects in the fields of Digital Health, Real-World Evidence and Market Access.

Clinical Trials Digital Health DTx Market Access Real-World Evidence RWE